The proANP ELISA (1-98) is intended for the quantitative determination of NT-proANP (1-98) in Human Plasma, Serum, Urine and Cell Culture supernatants.
Includes standards and controls
Validated for use with Human samples
Has been shown to detect NT-proANP in rat serum1
Excellent precision and reproducibility:
Intra-assay CV 2%
Inter-assay CV 4%
For Research Use Only. Not for Use in Diagnostic Procedures.
Atrial natriuretic peptide (ANP) is a 126 amino acid cardiac prohormone synthesized in atrial myocytes and is stored in secretory granules. Circulating levels of proANP (1-98) are typically measured because of its longer half-life and because they are less sensitive to the pulsatile secretion of ANP. proANP has been investigated in oxidative stress, sepsis, cardiac hypertrophy, and heart failure risk.
Vinken et al. (2016). Cross-laboratory analytical validation of the cardiac biomarker NT-proANP in rat. Journal of Pharmacological and Toxicological Methods 77 (2016) 58–65. PMID: 26516096.
Species
Human, Mouse, Rat
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
July 22, 2025 – Salem, NH – NuvinkaDx, a leading innovator in diagnostic solutions, today announced two significant product and regulatory milestones from its operating companies, GeneProof and ALPCO.
Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.
Complement System Solutions for Drug Development and Clinical Research Datasheet
The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.
Melatonin Products for Sleep Disorder-Related Research Datasheet
The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.
